7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Miyaji Y et al. | Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. | 2009 | Xenobiotica | pmid:19255937 |
Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
Fahrleitner-Pammer A et al. | Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. | 2003 | Wien. Klin. Wochenschr. | pmid:12793029 |
Fahrleitner A et al. | Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. | 2002 | Wien. Klin. Wochenschr. | pmid:12602117 |
Wagner D and Fahrleitner-Pammer A | Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? | 2010 | Wien Med Wochenschr | pmid:20714810 |
Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
Beke D et al. | [Clinical relevance of biomarkers in cancer related bone disease]. | 2007 | Wien Med Wochenschr | pmid:17922085 |
Kerschan-Schindl K | Bone turnover in hyperparathyroidism. | 2013 | Wien Med Wochenschr | pmid:22805761 |